Public procurement notice: Contract Notice
Published: 2019-05-21
Buyer: NHS Supply Chain Operated by DHL Supply Chain Ltd acting as agent of Supply Chain Coordination Ltd (SCCL)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33140000: Medical consumables | 33141600 | 33194000
Estimated value: 32000000 GBP
Submission deadline: 2019-06-03
Award criteria: The most economic tender

Technical requirements: NHS Supply Chain seeks to establish a non-exclusive Framework Agreement for supply to NHS Supply Chain depots via the Stock/Blue Diamond routes and to the NHS Supply Chain customer base via the E-Direct Route.
The Framework Agreement is for the supply of wound drainage, post-operative and intra-operative autologous blood system products and consumables.
The Framework Agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.
It is anticipated that in the first 24 months of the Framework Agreement the value of purchases will be circa 16 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 32 000 000 GBP. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business.
Wound drainage products are used in a medical environment to drain excess fluid from a wound to prevent infection and speed up the healing process. These are used post-surgery or after medical procedures and will aid in the healing process.
This lot includes, but is not limited to, wound drainage products such as low vacuum wound drainage systems, high vacuum wound drainage systems, passive/gravity wound drainage systems, silicon drains and wound drainage system accessories.
It is anticipated that in the first 24 months of the Framework Agreement the value of purchases for this Lot will be circa 5 200 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 10 400 000 GBP.
The Framework Agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.
Post-operative autologous blood systems are used for the collection of blood from a single patient to be stored and then re-transfused at a later date. Typically the products are used procedures in advance of surgery which has high blood loss associated like joint replacements or spinal surgery.
This lot includes, but is not limited to, post-operative autologous blood system products such as post-operative auto transfusion kits and associated consumables, bottles, blood salvage systems and associated consumables/accessories.
It is anticipated that in the first 24 months of the Framework Agreement the value of purchases for this lot will be circa 1 800 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 3 600 000 GBP.
The Framework Agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.
Intra-operative autologous blood systems are used to clean blood and recover red blood cells during surgery. Once the blood has been washed to remove unwanted blood components, the red blood cells are then reinfused.
This lot includes, but is not limited, intra-operative autologous blood system products such as bowls, processing sets, reinfusion bags, reservoirs, sequestration sets, suction lines, suction tubing, waste bags consumables and intra-operative autologous cell salvage blood machines
It is anticipated that in the first 24 months of the Framework Agreement the value of purchases for this lot will be circa 1 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 2 000 000 GBP.

Eligibility requirements: Applicants should refer to II.2) of this Contract Notice for further details in respect of appointment to the individual lots across the Framework Agreement. Applicants may bid for 1, more than 1 or all of the lots and applicants should refer to the invitation to tender for more information in respect of this. The term of contracts formed under the Framework Agreement may continue beyond the end of the term of the Framework Agreement itself. NHS Supply Chain expects to provide successful suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing, value-added offerings and commitment initiatives. NHS Supply Chain will share savings information in order to assist its customers with making informed procurement decisions. NHS Supply Chain intends to enter into arrangements under which it will be entitled to purchase supplies and/or services which it will make available for purchase by: 1) Any NHS Trust; 2) Any other NHS entity; 3) Any government department, agency or other statutory body (for the avoidance of doubt including local authorities); and/or 4) Any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it. Electronic ordering will be used and electronic invoicing will be accepted and electronic payment will be used. For the avoidance of doubt, and notwithstanding the estimate indicated at II.1.5), NHS Supply Chain does not guarantee any level of purchase through the framework and advises Applicants that the framework shall be established on a non-exclusive basis. Tenders and all supporting documentation for the contract must be priced in sterling and written in English. Any agreement entered into will be considered a contract made in England according to English law and will be subject to the exclusive jurisdiction of the English Courts. NHS Supply Chain is not liable for any costs (including any third party costs, fees or expenses incurred by those expressing an interest, participating or tendering for this contract opportunity. NHS Supply Chain reserves the right to terminate the procurement process (or part of it), to change the basis of and the procedures for the procurement process at any time, or to procure the subject matter of the contract by alternative means if it appears that it can be more advantageously procured by alternative means. The most economically advantageous or any tender will not automatically be accepted. All communications must be made through NHS Supply Chain's eTendering portal at http://procurement.supplychain.nhs.uk/ISS/ using the Message Centre facility linked to this particular Contract Notice. Please note that the maximum number of suppliers as set out in IV.1.3) is an estimate only.

Award value: 32000000